Apogee Therapeutics, Inc.

APGE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$134.11+0.01%

2026-08-03

Financials

Valuation Metrics

Apogee Therapeutics, Inc.'s Market Cap is $10.11B. At end of 2025 it was $4.58B. Ranked #942 of 3,112 in US market (top 30%), #302 of 1,445 on NASDAQ (top 21%), #45 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 17%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$10.11B	US#942/3,112 Sec#45/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-275M	US—/3,112 Sec—/269
Total Assets	$1.29B	US#2,322/3,112 Sec#80/269
Net Assets	$1.26B	US#1,614/3,112 Sec#52/269
Value
P/B	8.05x	US#2,497/3,112 Sec#189/269
FCF Yield	-2.33%	US—/3,112 Sec—/269
Profitability
ROE	-21.87%	US#2,543/3,112 Sec#107/269
ROA	-21.23%	US#2,788/3,112 Sec#128/269
Financial Health
Debt Ratio	3.01%	US#24/3,112 Sec#5/269
Total Debt	$8M	US#2,803/3,112 Sec#206/269
FCF	$-235M	US#2,753/3,112 Sec#226/269
Cash	$452M	US#1,136/3,112 Sec#61/269
Current Ratio	32.59x	US#75/3,112 Sec#6/269
Performance
1Y Return	255.26%	US#63/3,112 Sec#22/269
1M Return	0.90%	US#1,512/3,112 Sec#64/269
From 52W High	-0.26%	US#30/3,112 Sec#3/269
1Y MDD	-26.99%	US#1,152/3,112 Sec#65/269
Trading
Volume	1,054,832 shares	US#1,420/3,112 Sec#141/269
Trading Value	$141M	US#688/3,112 Sec#42/269
Per Share
EPS	$-4.22	US—/3,112 Sec—/269
BPS	$14.89	US#1,484/3,112 Sec#47/269